What Myomo, Inc. does.

We are a wearable medical robotics company that offers functional improvement for those with neuromuscular disorders and upper limb paralysis. We develop and market the MyoPro product line. A MyoPro is a myoelectric-controlled upper limb brace, or orthosis. The orthosis is a rigid brace used for the purpose of supporting a patient’s weak or paralyzed arm to enable and help improve functional activities of daily living, or ADLs, in the home and community. It is custom-fabricated by trained professionals during a custom fabrication process for each individual user to meet their specific needs. Our products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury and other neurological disorders. We primarily provide devices directly to patients and bill their insurance companies directly, a sales channel we refer to as direct billing. Under direct billing, we evaluate, measure and fit the MyoPro devices using our own clinical staff or as circumstances dictate, utilize the clinical consulting services of orthotics and prosthetics, or O&P. We also sell our products through various other sales channels, including through O&P providers, which we expect to be a larger contributor to revenue in the future, the Veterans Administration, or VA, and to certain accounts and geographic markets outside the United States. We operate as one business segment.

Revenue and profit, by fiscal year.

More on MYO.

• Myomo, Inc. summary
• Myomo, Inc. financial statements
• Myomo, Inc. key metrics
• Myomo, Inc. health scores and style box
• Myomo, Inc. earnings
• Myomo, Inc. dividends
• Myomo, Inc. valuation
• Myomo, Inc. ownership and insiders
• Myomo, Inc. peers

Figures from Myomo, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.